1 Food&Drug Allergy .May 2006-
-
Upload
goekhan-tazeguel -
Category
Documents
-
view
218 -
download
0
Transcript of 1 Food&Drug Allergy .May 2006-
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 1/43
ADVERSE REACTIONS TOFOODS
Pediatric Allergy-Immunology Division
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 2/43
Prevalence
Children 6-8%
Adults 1-2%
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 3/43
A term referring to any reaction
after ingestion of food
Definition
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 4/43
A- Non-immunologic Reaction
Toxic
Bacterial food poisoning
(salmonella, staphylococcus)
Scromboid fish poisoning(Histamine)
Pharmacologic
Caffeine in coffee
Alcohol
Tyramine in aged cheese
Metabolic/ Intolerance
Lactose deficiency-intolerance
Galactosemia
Pancreatic Insufficiency
Idiosynrotic
Food additives
Aspirin
NSAID
Phsycologic
Anorexia nervosa
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 5/43
B- Immunologic reactions
IgE mediated Non- IgE mediated
Oral allergy syndrome
Anaphylaxis
Urticaria
Eosinophilic gastroenteritis
Food induced enterocolitis
Food induced colitis (proctitis)
Dietary protein enteropathy
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 6/43
Pathophysiology
Barrier Mechanisms: Prevent ag invading blood stream
A- Non-immunologic
Gastic and pancreatic enzymes
Intestinal peristaltism
Intestinal mucosa
Microvilli
Cell barrier
B- Immunologic
Secretary IgA
RES cells
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 7/43
ORAL TOLERANCE
State of immunologic unresponsiveness to food ag¶s
Newborn-age related immaturity of barrier mechanisms
Tolerizing mechanisms subsequently developes
Early feeding with major food ag¶s prevents tolerance
and sensitizes
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 8/43
Immune Mechanisms
A. IgE-mediated
Genetic lack of development of oral toleranceBreakdown of tolerance in the GI tract
B. Non IgE-mediated
Limited scientific evidenceType I, II, III, IV rxs
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 9/43
Major Food Allergens
Children
Cow¶s milk (whey proteins, casein)
Egg (ovalbumin)
Peanut
Soy-bean
Wheat
Fish
Tree-nut
Adults
Peanut
Tree-nutFish
Shellfish
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 10/43
A- IgE Mediated
Prick ( RAST(+) )
Symptoms develop in minutesOral Allergy Syndrome
Contact urticaria
Confined to oroparynx
Pruritis-angioedema (tongue, lip, palate, throat)
Rapidly resolves
Fresh fruit and vegetables
Clinical Manifestations
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 11/43
Anaphylaxis
Cutaneous, respiratory, GI, CV symptoms
May be fatal
Exercise induced anaphylaxis
Nuts and fish
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 12/43
Respiratory Symptoms
Nasal ± rhinorrea, pruritis, sneezing
Larygeal ± dysphonia, hoarsness, laryngeal edema,
upper airway obstruction
Bronchial-wheezing Skin
Acute urticria
Chronic urticaria
Atopic dermatitis
Milk, egg, fish, peanut, soya
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 13/43
(a)GI allergy nausea vomiting
abdominal pain
cramping
diarrhea
(b) Allergic eosinophilic gastroentheropathy nausea vomiting
abdominal pain
diarrhea
failure to thrive in infants
(c) Infantfil colic 10-15 % IgE mediated
proxysmal crying, abdominal distension, excessive gus, flexion
of legs in the first 2-4 wks of life
GI
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 14/43
Symptoms develop 2-4 hrs after food ingestion
Prick ( RAST (-) )
B- Non ± IgE mediated
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 15/43
GASTROINTESTINAL
Enterocolitis Colitis Enteropathy
Age onset Infant Infant/newborn Infant/Toddler
Symptoms Vomiting Vomiting Vomiting
Diarrhea Diarrhea Diarrhea
Rectal bleeding Rectal bleeding Poor weight gain
ill apprence
Characteristic Prot. Losing entheropathy
Malabsorbtion Malabsorption
Edema
Dehydration
Acidosis
Causes Milk Milk Milk
Soy Soy Soy
Protein formulas Human milk Wheat
Egg
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 16/43
Diagnosis: History/Physical
History:
-symptoms, timing: Acute rx versus chronich rx-Diet details / symptom diary: specific food(s), hidden
ingredient
Physical examination:
evaluate disease severityIdentify general mechanism
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 17/43
DIAGNOSISHx/Physical Exam
Identify general mechanism
IgE-mediated
Prick RAST (+) Non IgE-mediated
Prick RAST (-)
Consider biopsy
ELIMI NATION
Resolution No Resolution
Consider biopsy
Challenge
Elimination
Challenge
Reintroduce
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 18/43
Only proven treatment isELIMINATION
Treatment
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 19/43
Wheezing - F2
agonists
Sneezing
Urticaria
Angioedema
Pruritis
Anaphylaxis - adrenalin
antihistamines
Treat Symptoms
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 20/43
Only if ³High risk´ infant
Delayed introduction of solid foods Milk 12 months
Egg 24 months
Fish/peanut 36 months
Prophylaxis
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 21/43
Both parents with atopic disease
Siblings with food allergy
Who is high risk?
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 22/43
Natural History
Dependent on food and immunopathogenesis
IgE-mediated GI allergy
85% CM, egg, wheat, soy allergy remit by 3
yrs
Levels of specific IgE not predictive
Allergy to peanut, nut, seafood persist
Non IgE-mediated GI allergy
Infant forms resolve 1-3 yrs
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 23/43
Summary
History and Physical exam important
IgE & non-IgE mediated conditions exist
Diagnosis by elimination and challenge
Elimination/education/emergency treatment
Periodic rechallenge to monitor tolerance
S pecific IgE does not indicate tolerance
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 24/43
Any rx after administration of drug
ADVERSE REACTIONS TO DRUGS
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 25/43
A- Predictable (non-susceptible patients)
(1)Overdosage
Toxic pharmacologic efect
e.g. - Respiratory depression with sedatives
- Grand mal seizure with aminophyline
Classification of Adverse Drug Reactions
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 26/43
(2) Side effect ± undesirable but unavoidable effect
e.g Somnolence with antihistamines
Tachycardia with adrenalin
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 27/43
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 28/43
(4) Drug interactions
Alteration of drug metabolism by another drug
e.g Phenobarbital increases metabolism of teophylline
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 29/43
(1) Intolerance
- Toxic pharmacologic effect by normal dose
- Defect in the metabolism of drug
e.g convulsion with normal dose of aminophyline
B- Un-predictable (susceptible patients)
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 30/43
(2) IdiosyncrasyA bnormal response different than pharmacologic effect
- related to any enzyme deficiency
e.g coombs (+) hemolytic anemia in subjects with
GGPD deficiency with use of primaquine
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 31/43
(3) Allergy or Type I HS - ANAFLAKTK - Immune mechanism
- Exposure-latent period-re exposure ± rx (not on 1st exp)
- Symptoms different than pharmacologic effect
- May start with small doses
- Subsides when drug discontiuned
- Reccurs wen drug readministered
- e.g penicillin, sulphonamide
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 32/43
(4) Pseudoallergic rxs - ANAFLAKTOD- non - immune mechanism
- 1st exposure
- high dose
e.g anaphylactoid ± RCM, vancomisin
defect in arachidonic acid pathway-aspirin, NSAID
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 33/43
HAPTENIZATION
Drugs ³low molecular weight´ ³non immunogenic´
Drug-Protein conjugates =>Hapten
³Hapten´ is immunogenic
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 34/43
Immunologic Classification of Drug rxs
Type I, II, III, IV immunologic reactions
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 35/43
(1)History
Most important diagnostic tool
Identify all drugs used
Time of symptoms to start
Route
Duration of tx
Clinical manifestations
Duration of subsiding following discontinuation
Approach to patient with history of drug allergy
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 36/43
(2) Don¶t give drugs with CROSS-REACTIVITY
e.g ±Penicilin and cephalosporine
-Give another drug
(3) If that drug INDICATED
Skin test (Prick , intradermal) (IgE mediated)
Incremental challenge test (anaphylactoid)
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 37/43
(4) - Desensitization p start treatment
(5) If Type II, III, IV, rx
Never give the drug
No method for desensitization
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 38/43
Most common cause
Allergic rx 0,75-8 %
Systemic anaphylaxis 0.01%
20-49 yrs of age
PENICILLIN ALLERGY
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 39/43
Immunopathologic Rx
Gell and Coombs classification
Type I, II, III, IV HS rx
Antigenic DeterminantsMajor determinant
- Benzyl penicilloyl
Minor determinant-Benzyl penicillin
-Benzyl penicilloate
- Benzyl penilloate
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 40/43
(1) History
(2) Hx of Type I HS rx ± AVOID
(3) Have to use ± skin test
(4) Test only relevant to current situation ± NOT FUTURE
(5) Non-IgE mediated rx ± NOT PREDICTED by test
Diagnosis & Approach
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 41/43
(1) AVOID
(2) AVOID dugs with CROSS-REACTIVITY (posses-beta lactams)
Cephalosporins (1-16 %CR)
Monobactam
Cephacarbam 50 %CR
Carbopenem
Management of Patient with (+) Skin Test
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 42/43
(3) Desensitization
IndicatedpWhen no suitable alternative AB for substitution
PO/ Parenteral (PO safer)
Start with extremely small dosep doubling 15 mtsp Full dosepTx
Only relevant for current tx
8/3/2019 1 Food&Drug Allergy .May 2006-
http://slidepdf.com/reader/full/1-fooddrug-allergy-may-2006- 43/43
(4) Future courses of penicillin needed
Repeat skin test
Repeat desensitization